Author

Agata Michalak

EFFECTIVENESS AND SAFETY OUTCOMES AFTER LONG-TERM (54 WEEKS) VEDOLIZUMAB THERAPY FOR CROHN'S DISEASE: A PROSPECTIVE, REAL-WORLD OBSERVATIONAL STUDY INCLUDING PATIENT-REPORTED OUTCOMES (POLONEZ II)
EFFECTIVENESS AND SAFETY OUTCOMES AFTER LONG-TERM (54 WEEKS) VEDOLIZUMAB THERAPY FOR CROHN'S DISEASE: A PROSPECTIVE, REAL-WORLD OBSERVATIONAL STUDY INCLUDING PATIENT-REPORTED OUTCOMES (POLONEZ II)

Agata Michalak  et al.

BIOELECTRICAL IMPEDANCE ANALYSIS AND HEMATOLOGICAL SCALES - A BRAND NEW COMBINATION FOR THE EVALUATION OF IBD PATIENTS?
BIOELECTRICAL IMPEDANCE ANALYSIS AND HEMATOLOGICAL SCALES - A BRAND NEW COMBINATION FOR THE EVALUATION OF IBD PATIENTS?

Agata Michalak  et al.

MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS
MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS

Agata Michalak  et al.

NON-ALCOHOLIC FATTY LIVER DISEASE INVOLVES DEVIATIONS IN MICRORNAS AND HEMATOLOGICAL INDICES - A SINGLE CENTRE OBSERVATION
NON-ALCOHOLIC FATTY LIVER DISEASE INVOLVES DEVIATIONS IN MICRORNAS AND HEMATOLOGICAL INDICES - A SINGLE CENTRE OBSERVATION

Agata Michalak  et al.

MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS
MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS

EXPRESSION OF MICRORNAS IS CLOSELY RELATED TO DIRECT MARKERS OF LIVER FIBROSIS: A STUDY ON ALCOHOLIC LIVER CIRRHOSIS PATIENTS
EXPRESSION OF MICRORNAS IS CLOSELY RELATED TO DIRECT MARKERS OF LIVER FIBROSIS: A STUDY ON ALCOHOLIC LIVER CIRRHOSIS PATIENTS

Agata Michalak  et al.

PREVALANCE AND SIGNIFICANCE OF ASYMPTOMATIC CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS INFECTIONS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE - TO TREAT OR IGNORE?
PREVALANCE AND SIGNIFICANCE OF ASYMPTOMATIC CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS INFECTIONS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE - TO TREAT OR IGNORE?

Agata Michalak  et al.

Item 1 - 7 / 7
1